Boston Scientific to Explore Sale of Cardiac & Vascular Surgery Businesses
In recent months the firm has retained its endosurgery group, entered into an agreement to assume sole management and control of the pain management business from Advanced Bionics and sell the Advanced Bionics auditory business, monetised parts of its portfolio, and begun developing an expense and head count reduction plan, which it said it plans to announce next quarter.
Boston Scientific continues to focus on the recovery of the drug-eluting stent and cardiac rhythm management markets.
The SpiroScout SP incorporates the latest ultrasound technology and can be used in combination with SCHILLER ECG devices. This new concept offers many benefits, as it simplifies the handling of the measurements and the data management for both ECG and...